BioSpace News Archive

With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Brent Jones to Chief Commercial Officer effective November 1st, 2021.

Children’s Hospital of Philadelphia announced that it has received a significant philanthropic gift from Stanley C. Middleman, his wife Roslyn and the entire Middleman family to name CHOP’s second inpatient hospital, located in King of Prussia, PA.

Infinite Chemical Analysis Labs (“InfiniteCAL” or “the Company”), a full-service analytical testing lab for the cannabis and hemp industries, announced today the approval of their hemp testing certification to test products produced in Colorado. InfiniteCAL will be the first testing lab in the United States to be certified for all Colorado-specific requirements, which will take full effect January 1, 2022.

Enzychem Lifesciences (KOSDAQ: 183490), a late-stage biotechnology company, announced today that the Company has filed for Breakthrough Therapy designation (BTD) with the U.S. Food and Drug Administration (FDA) for the use of its lead investigational candidate in chemoradiation-induced oral mucositis (CRIOM).

Organon (NYSE: OGN) is pleased to announce NEXPLANON® (etonogestrel extended-release subdermal implant) public listing in Quebec under the Régie de l’assurance maladie du Québec (RAMQ) as of November 10.

Black Diamond Therapeutics, Inc., a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an update about the Company’s progress at the following upcoming investor conferences.

ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today reported financial results and operational updates for the quarter ended September 30, 2021.

NANO-X IMAGING LTD today announced the completion of its previously announced merger with Zebra Medical Vision, Ltd.

Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed James Paiva as its new Vice President, U.S. Marketing.

Ocugen, Inc. announced that it has submitted an Investigational New Drug application (IND) with the U.S. Food and Drug Administration (FDA) to initiate a Phase 1/2 clinical trial of OCU400 (AAV- NR2E3)